Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ASCO 2024
ASCO 2024
ASCO: Merck KGaA, Pfizer's Bavencio combo misses survival mark in crowded kidney cancer space
Fierce Pharma
Thu, 05/23/24 - 09:52 pm
ASCO 2024
Merck KGaA
Bavencio
Pfizer
Inlyta
kidney cancer
clinical tirals
ASCO: Bristol Myers unveils I-O triplet data in melanoma as Iovance touts ‘paradigm-changing’ combo result
Fierce Pharma
Thu, 05/23/24 - 09:46 pm
ASCO 2024
Bristol Myers Squibb
Iovance
melanoma
Opdualag
Yervoy
Pages
« first
‹ previous
1
2